Revvity
Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments.
Latest Revvity Content
Whitepaper
Accelerate Your NGS Workflows
This whitepaper highlights how vendor-qualified, automated library preparation methods can accelerate a variety of NGS workflows.
Product News
Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development
Revvity, Inc announced the launch of its Signals Research Suite, a unified, cloud-native SaaS platform that drives scientific collaboration across R&D disciplines from drug discovery to specialty chemicals material development.
App Note / Case Study
Novel High-Throughput Image Cytometry Method for T-Cell Immunophenotyping and Viability Readouts
The cell therapy manufacturing process requires the guidance of chemical manufacturing and controls for analytical method development focusing on the critical quality attributes (CQAs).
Infographic
The Great Story of Gene Therapy
Gene therapy aims to be a one-time treatment targeting a faulty gene that causes a disease and either replacing it with a functional gene or altering the gene expression.
How To Guide
Protein Degradation – A Guide to the Proteasome and Autophagy Systems
This guide explores the critical role of ubiquitin in two protein degradation systems, the ubiquitin-proteasome system (UPS) and the autophagy–lysosomal system (ALS), in proteostasis.
Advertisement
